| |
Development and introduced several new tools and
systems to the organization that help optimize product launches.
Martin joined Genentech several years ago as Director of Marketing in the
Cardiovascular Franchise. Prior to joining Genentech, Martin held various roles
of increasing responsibility in sales, sales management, marketing and business
development on a global as well as affiliate level with Eli Lilly and Company.
Martin Babler holds a degree in Pharmacy/Pharmacology from the ETH in Zurich,
Switzerland and has attended the Executive Development Program at Kellogg
Graduate School of Management.
Joseph A. Carlino, Ph.D.
Principal, Carlino Consulting
Joe Carlino is a drug development consultant with over 25 years experience in
the Life Sciences and Biopharmaceutical Industry. His 17 years in Project and
Program Management within the biotechnology industry have included a broad range
of clinical indications, therapeutic modalities, and corporate alliances. His
hands-on development experience has been built upon a strong scientific
foundation in biologics, small molecules, monoclonal antibodies, and traditional
pharmaceuticals. Joe’s scientific and development expertise is leveraged by his
clear and effective communication skills when working with corporate
stakeholders from the bench-top to the boardroom, and with community and
academic leaders.
Prior to his work with biotechnology clients in the SF Bay Area as Principal of
Carlino Consulting, Joe was at Chiron Corporation for 9 years, most recently as
Senior Director and Project Leader, Development Management, within the
BioPharmaceuticals Business Unit. He led and managed pre-clinical, clinical, and
commercial projects, primarily those being co-developed with corporate partners.
Prior to Chiron, Joe managed and directed projects at Collagen Corporation and
its spin-off, Celtrix Pharmaceuticals, for 9 years. His early scientific work
includes post-doctoral research at Cetus Corporation, and characterization of
malignancy-associated glucocorticoid receptors at Memorial Sloan-Kettering
Cancer Center. Joe received his Ph.D. in Pathobiology/Immunology from Columbia
University.
His experience in Development Management has included indications such as
psoriasis, multiple sclerosis, macular degeneration, mucositis, wound repair,
transplant rejection, infectious disease, and various solid and hematologic
oncology indications. Joe’s drug development presentations have included topics
such as the challenges of partnered projects; the effective use of budgets and
financial information by project teams; defining the value of enterprise project
management systems; explicit definition of accountability and authority to
efficiently execute drug development plans; and, defining stage-gates and the
decision-making authority within corporations to efficiently progress through
them. Joe holds six patents, has numerous scientific publications, is an active
member of the Drug Information Association (DIA), is an Advisory Board member to
the Tufts Center for the Study of Drug Development, and contributes to the
management of PMPharma, a project management professional association in the San
Francisco Bay Area.
Brad Dawson
Director, Life Sciences Consulting practice, Conformia Software, Inc.
Brad Dawson is a Director in the Life Sciences consulting practice of
Conformia Software, Inc. Mr. Dawson is a seasoned strategy and operations
consultant with nine years world-class management consulting experience leading
complex pharmaceutical strategy, business process, and supply chain improvement
initiatives. He is highly experienced at solving complex business operational
challenges through rigorous analytical and quantitative analysis and business
process redesign. Specialized in supply chain strategy and design, Mr. Dawson
has lead numerous global supply chain optimization and redesign projects for
many leading pharmaceutical companies.
Prior to joining Conformia Software, Brad spent eight years with the Life
Science consulting practices of Deloitte Consulting and Ernst & Young where he
developed deep pharmaceutical strategy and operational expertise. Mr. Dawson has
managed many large scale business process improvement and growth strategy
engagements which have significantly reduced costs, improved operation
efficiencies, and positioned the client with a competitive edge in the
marketplace.
A graduate of UCLA, Mr. Dawson holds BS in Psychobiology and Biostatistics.
Michael Eckstut
Vice President of Business Operations - Life Sciences,
Conformia Software Inc.
Michael Eckstut is the Vice President of Business Operations - Life Sciences
for Conformia Software Inc. Michael is an experienced senior business
professional with a broad range of business and operational experience in large,
small and early stage companies in the life science and chemical industries as
an executive, investor, advisor and board member. Mr. Eckstut has extensive
experience building practice areas and consulting to major pharmaceutical and
life sciences companies: - At A.T. Kearney, he was Vice President and head of
the chemicals and pharmaceuticals practice with total staff of over 40
professionals working worldwide. He led numerous engagements in the
pharmaceuticals and medical device industries in supply chain /e-commerce
linkages, strategic sourcing, and other major business process re-engineering
efforts as well as implementation of major ERP systems. Mr. Eckstut also led
strategy and organization development assignments to extend product patent life,
“re-purpose” products and increase R&D portfolio value. - At Booz Allen &
Hamilton, he was Vice President and head of the chemicals and pharmaceuticals
practices and served as a member of the Booz Allen board of directors from
1991-1993 and head of the New York Office in 1989-1990. Mr. Eckstut led the
development of initial business strategies for early stage biotechnology firms
in the early 1990's, two of which have grown to be leaders in their field, and
aided in licensing strategy development to build out therapeutic area
strategies. Mr. Eckstut also has extensive experience marketing, selling and
delivering enterprise software for the Life Sciences industry: - At Model N, he
was Vice President, Vertical markets and developed the health care and life
sciences market approach, identified target customers and selling strategy,
built the tangible value proposition (significant sales improvement benefits
identified through a facilitated opportunity assessment) and built a
cross-functional pre-sales team to deliver the strategy for the company's
pricing and revenue management applications. - At Velosel he was Senior Vice
President, Strategic Alliances and Services for this applications company
focusing on supplier enablement and content management and led the closing of
the initial Beta customer and first commercial customer. He was COO of its
predecessor company (MartQuest) responsible for all sales, marketing,
professional services and business development. - At Chem Connect, he served as
Senior Vice President, Business Development, for the pioneer online chemicals
and plastics marketplace and exchange. Mr. Eckstut is also active at various
levels in the life science industry at large: - As co-Chair of the Health Care
and Life Sciences Committee of the Keiretsu Forum, an early-stage investment
community of accredited private equity investors, venture capitalists and
corporate/institutional investors with multiple locations in the US - As a
member of the Board of Advisors of several early stage companies in health care
services, biotechnology and R&D Lead Development. - As advisor and coach to the
Spingboard Silicon Valley 2004 participants. He holds a BS and MS cum laude in
Chemical Engineering from Rensselaer Polytechnic Institute and an MBA (as a
Baker Scholar) from the Harvard Graduate School of Business Administration.
Douglas I. Kalish
Educator, Consultant
Douglas I. Kalish, Ph.D. is an educator, consultant
and serial entrepreneur who has founded or been an early executive in three
companies. With a deep technology background and over 30 years of management
experience, Doug provides strategic business and product advice to the
information technology and biotechnology industries, with an emphasis on
collaboration, and knowledge and content management.
As a Lecturer, Doug taught 'The Business of Biotechnology' at the UC-Berkeley
Haas Business School and created a three-part online course entitled
'Fundamentals of Drug Discovery' for the Stanford Center for Professional
Development. From 1998 to 2001, he served as the Vice President and Chief
Knowledge Officer at Scient. Prior to joining Scient, Doug was a Managing
Partner of the Price Waterhouse Technology Centre.
Doug holds an AB in Neurobiology from Michigan and PhD in Biology from Harvard
University
|
